EQT VIII Sells Galderma Group AG Shares to L'Oréal S.A.

EQT Sells Karo Healthcare to KKR

April 11, 2025

Healthcare Services

EQT VIII has agreed to sell Karo Healthcare, a pan-European consumer healthcare platform headquartered in Stockholm, Sweden, to KKR. The deal is expected to close in the coming months, subject to customary regulatory approvals.

Galderma Acquires ALASTIN Skincare

January 5, 2022

Healthcare Services

Galderma has completed the acquisition of ALASTIN Skincare, Inc., receiving U.S. antitrust clearance and closing the deal announced November 29, 2021. The purchase adds ALASTIN's physician-dispensed aesthetic skincare portfolio, including its patented TriHex Technology, to Galderma's integrated dermatology platform to expand product capabilities and better serve aesthetic professionals and consumers.

EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management

July 2, 2021

Healthcare Services

EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.

PEAL Capital Group Acquires Majority Stake in Derma Medical

May 20, 2022

Healthcare Services

Female-founded private equity firm PEAL Capital Group has acquired a majority shareholding in Derma Medical (Derma Med Ltd), the UK’s leading cosmetic/aesthetic training provider. The investment will provide operational expertise and capital to accelerate Derma Medical's international expansion and scaling, with Jennifer Fox joining as Executive Chair.

EQT Future and ATHOS Lead Minority Investment in SHL Medical

December 9, 2022

Medical Devices

EQT Future, ATHOS and other co-investors have acquired a minority stake in SHL Medical from EQT's Equity fund VIII, with founder Roger Samuelsson remaining the majority shareholder. The consortium will support SHL Medical's next growth phase — expanding production into the United States and Europe, launching new product platforms, and advancing sustainability and circularity initiatives.

L'Oréal Acquires Skinbetter Science

September 23, 2022

Consumer Products

L'Oréal has signed an agreement to acquire Skinbetter Science, a physician-dispensed U.S. skincare brand known for dermatology-backed, clinical formulations. Skinbetter Science—headquartered in Phoenix, Arizona and reporting nearly $95 million in trailing‑12‑month sales to August 31, 2022—will be integrated into L'Oréal USA's Active Cosmetics Division while its leadership team remains in place.